Literature DB >> 19702782

Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation.

Ping Li1, Achintya K Bandyopadhyaya, Douglas F Covey, Joe Henry Steinbach, Gustav Akk.   

Abstract

BACKGROUND AND
PURPOSE: Potentiating neurosteroids are some of the most efficacious modulators of the mammalian GABA(A) receptor. One of the crucial interactions may be between the C20 ketone group (D-ring substituent at C17) of the neurosteroid, and the N407 and Y410 residues in the M4 domain of the receptor. In this study, we examined the contribution of hydrogen bonding between 17beta-substituents on the steroid D-ring and the GABA(A) receptor to potentiation by neurosteroids. EXPERIMENTAL APPROACH: Whole-cell and single-channel recordings were made from HEK 293 cells transiently expressing wild-type and mutant alpha1beta2gamma2L GABA(A) receptors. KEY
RESULTS: A steroid with a 17beta-carbonitrile group (3alpha5alpha18nor17betaCN) was a potent and efficacious potentiator of the GABA(A) receptor. Potentiation was also shown by a cyclosteroid in which C21 and the C18 methyl group of (3alpha,5alpha)-3-hydroxypregnan-20-one are connected within a six-membered ring containing a double bond as a hydrogen bond acceptor (3alpha5alphaCDNC12), a steroid containing a 17beta-ethyl group on the D-ring (3alpha5alpha17betaEt) and a steroid lacking a 17beta-substituent on the D-ring (3alpha5alpha17H). Single-channel kinetic analysis indicates that the kinetic mechanism of action is the same for the neurosteroid 3alpha5alphaP, 3alpha5alpha18nor17betaCN, 3alpha5alphaCDNC12, 3alpha5alpha17betaEt and 3alpha5alpha17H. Interestingly, 3alpha5alpha17betaEt, at up to 3 microM, was incapable of potentiating the alpha1N407A/Y410F double mutant receptor. CONCLUSIONS AND IMPLICATIONS: Hydrogen bonding between the steroid 17beta-substituent and the GABA(A) receptor is not a critical requirement for channel potentiation. The alpha1N407/Y410 residues are important for neurosteroid potentiation for reasons other than hydrogen bonding between steroid and receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702782      PMCID: PMC2782341          DOI: 10.1111/j.1476-5381.2009.00390.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Atomic structure of progesterone complexed with its receptor.

Authors:  S P Williams; P B Sigler
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

2.  Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events.

Authors:  F Qin; A Auerbach; F Sachs
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

3.  Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.

Authors:  D M Tanenbaum; Y Wang; S P Williams; P B Sigler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

5.  In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformation.

Authors:  M B Bolger; S Wieland; J E Hawkinson; H Xia; R Upasani; N C Lan
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

6.  Neurosteroid analogues. 4. The effect of methyl substitution at the C-5 and C-10 positions of neurosteroids on electrophysiological activity at GABAA receptors.

Authors:  M Han; C F Zorumski; D F Covey
Journal:  J Med Chem       Date:  1996-10-11       Impact factor: 7.446

7.  Neurosteroid access to the GABAA receptor.

Authors:  Gustav Akk; Hong-Jin Shu; Cunde Wang; Joe Henry Steinbach; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

8.  Dual potentiating and inhibitory actions of a benz[e]indene neurosteroid analog on recombinant alpha1beta2gamma2 GABAA receptors.

Authors:  Ping Li; Douglas F Covey; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2006-03-22       Impact factor: 4.436

9.  Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor.

Authors:  Ping Li; John Bracamontes; Bryson W Katona; Douglas F Covey; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2007-03-06       Impact factor: 4.436

10.  Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.

Authors:  Alastair M Hosie; Megan E Wilkins; Helena M A da Silva; Trevor G Smart
Journal:  Nature       Date:  2006-11-15       Impact factor: 49.962

View more
  10 in total

1.  Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor.

Authors:  Zi-Wei Chen; Brad Manion; R Reid Townsend; David E Reichert; Douglas F Covey; Joe Henry Steinbach; Werner Sieghart; Karoline Fuchs; Alex S Evers
Journal:  Mol Pharmacol       Date:  2012-05-30       Impact factor: 4.436

2.  Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site.

Authors:  John Bracamontes; Megan McCollum; Caroline Esch; Ping Li; Jason Ann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

3.  11-trifluoromethyl-phenyldiazirinyl neurosteroid analogues: potent general anesthetics and photolabeling reagents for GABAA receptors.

Authors:  Zi-Wei Chen; Cunde Wang; Kathiresan Krishnan; Brad D Manion; Randy Hastings; John Bracamontes; Amanda Taylor; Megan M Eaton; Charles F Zorumski; Joseph H Steinbach; Gustav Akk; Steven Mennerick; Douglas F Covey; Alex S Evers
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

4.  A novel mechanism of modulation of 5-HT₃A receptors by hydrocortisone.

Authors:  Jeremías Corradi; Natalia Andersen; Cecilia Bouzat
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

Review 5.  GABAA receptors: structure, function, pharmacology, and related disorders.

Authors:  Amr Ghit; Dina Assal; Ahmed S Al-Shami; Diaa Eldin E Hussein
Journal:  J Genet Eng Biotechnol       Date:  2021-08-21

6.  Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids.

Authors:  Gustav Akk; Douglas F Covey; Alex S Evers; Steven Mennerick; Charles F Zorumski; Joe Henry Steinbach
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

7.  A neurosteroid potentiation site can be moved among GABAA receptor subunits.

Authors:  John R Bracamontes; Ping Li; Gustav Akk; Joe Henry Steinbach
Journal:  J Physiol       Date:  2012-09-17       Impact factor: 5.182

8.  Comparison of Steroid Modulation of Spontaneous Inhibitory Postsynaptic Currents in Cultured Hippocampal Neurons and Steady-State Single-Channel Currents from Heterologously Expressed α1β2γ2L GABA(A) Receptors.

Authors:  Sampurna Chakrabarti; Mingxing Qian; Kathiresan Krishnan; Douglas F Covey; Steven Mennerick; Gustav Akk
Journal:  Mol Pharmacol       Date:  2016-01-14       Impact factor: 4.436

9.  Photoaffinity labeling identifies an intersubunit steroid-binding site in heteromeric GABA type A (GABAA) receptors.

Authors:  Selwyn S Jayakar; David C Chiara; Xiaojuan Zhou; Bo Wu; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2020-06-15       Impact factor: 5.157

10.  Multiple functional neurosteroid binding sites on GABAA receptors.

Authors:  Zi-Wei Chen; John R Bracamontes; Melissa M Budelier; Allison L Germann; Daniel J Shin; Krishnan Kathiresan; Ming-Xing Qian; Brad Manion; Wayland W L Cheng; David E Reichert; Gustav Akk; Douglas F Covey; Alex S Evers
Journal:  PLoS Biol       Date:  2019-03-07       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.